Zhongchao Inc.

ZCMD Healthcare Health Information Services

Zhongchao Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.4 million, down 28.3% from fiscal 2024.

1.29 0.10 −7.19%
Market cap
$6.2M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
3/9
Altman Z
9.11
Beneish M
−4.20
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Piotroski F-Score
3 5 6 2 4 3 — — —
P/E ratio
0.00 0.00 0.00 0.00 139,402.11 74,400.00 25.00 25.00 25.00
Altman Z-Score
9.11 6.77 2.62 7.26 16.08 18.95 — — —
P/S ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
15.87 17.89 6.22 9.18 14.11 17.78 13.19 10.75 —
P/Operating CF
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Beneish M-Score
(4.20) (1.11) (5.32) (2.43) (2.72) (0.74) (0.43) — —
P/B ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
(0.41) (0.38) (0.39) (0.37) (0.39) (0.50) 0.00 0.00 0.00
EV/EBITDA
1.88 1.76 1.81 6.06 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
(6.59) 5.02 3.90 (3.75) (12.66) 4.97 0.00 0.00 0.00
EV/FCF
3.22 1.47 2.76 9.54 4.63 2.94 0.00 0.00 0.00
Quick Ratio
10.94 11.61 5.97 4.57 6.64 9.20 5.48 4.75 3.90
Current Ratio
11.11 12.22 6.99 5.45 7.59 9.92 6.15 5.38 4.10
Net Debt/EBITDA
2.36 118.73 1.05 4.68 (679.96) (3.65) (2.09) (2.52) (4.51)
Debt/Assets
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 5.18% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.00
Asset Turnover
0.45 0.63 0.62 0.38 0.46 0.68 0.94 1.83 0.93
Operating CF/Net income
(0.13) 2.29 0.00 0.23 11.99 (0.23) 0.35 0.43 (0.35)
Capex/Depreciation
(0.53) (13.18) (1.56) (1.31) (5.27) (0.79) (12.76) (28.08) 0.00
Interest Coverage
— — — — — — — — 121.23
ROE
(27.00%) (2.85%) (41.94%) (8.97%) 0.74% 18.90% 30.29% 36.39% 18.40%
ROA
(25.22%) (2.56%) (35.97%) (7.85%) 0.67% 16.97% 25.46% 42.99% 14.55%
ROIC
(44.60%) (1.93%) (109.36%) (8.80%) (1.09%) 19.05% 30.33% 67.54% 0.00%
Return on Tangible Assets
(29.61%) (2.79%) (58.87%) (13.11%) 0.87% 15.58% 28.82% 27.71% 31.21%
Average Days of Receivables
89.29 107.73 47.94 180.53 215.26 209.42 124.90 56.55 48.40
Research and Development Expense of Revenue
0.07% 1.59% 2.65% 2.91% 4.66% 4.54% 5.81% 11.25% 9.61%
Selling, General and Administrative Expense of Revenue
99.38% 56.74% 68.99% 62.89% 55.23% 36.50% 38.44% 28.66% 39.27%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.17 0.01 0.00 0.02 0.03 0.00
Share Based Compensation of Revenue
32.57% 0.69% 0.70% 1.14% 1.30% 0.94% 1.08% (0.11%) 0.00%
Graham Net Nets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(0.05%) (0.01%) (0.01%) 0.00% 0.00% 0.00% 4.00% 4.00% 4.00%
Free Cash Flow Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Revenue per Share
309.10 2,266.40 5,552.54 4,043.29 4,793.18 5,451.45 5,132.00 4,594.96 0.39
Operating CF per Share
22.97 (210.46) 15.49 (189.06) 841.71 (314.48) 485.52 468.79 (0.02)
Capex per Share
(4.15) (435.03) (230.89) (143.86) (529.38) (48.67) (452.72) (388.07) 0.00
Free Cash Flow per Share
18.83 (645.49) (215.40) (332.91) 312.32 (363.15) 32.79 80.71 (0.02)
Cash per Share
378.33 1,869.11 3,841.86 3,439.69 4,179.74 5,183.61 2,700.90 3,243.64 0.19
Shareholders Equity per Share
614.08 3,450.16 6,010.91 9,434.09 9,578.35 9,646.70 5,289.14 4,066.21 0.21
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
614.08 3,450.16 6,010.91 9,434.09 9,578.35 9,646.70 5,289.14 4,066.21 0.21
Free Cash Flow
0.69 (4.52) (0.75) (1.17) 1.06 (1.20) 0.10 0.23 (0.54)
Working Capital
15.44 17.18 16.03 18.54 23.67 26.61 12.15 10.23 4.85
Capital Expenditures
(0.15) (3.05) (0.81) (0.50) (1.80) (0.16) (1.31) (1.09) (0.08)
Net Current Asset Value
15.41 16.97 15.33 17.11 23.55 26.61 12.11 9.90 4.85
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.01 0.19 0.04 0.04 0.11 0.01 0.09 0.08 0.00
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.05 0.04 0.16 0.10 0.09 0.10 0.05 0.06 0.31
Cash ROIC
1.90% (12.13%) (2.19%) (2.59%) 2.27% (2.45%) 0.41% 1.07% (5.37%)
Accounts Receivable Turnover
3.05 4.39 4.07 1.70 1.64 2.33 4.20 7.81 5.96
Accounts Payable Turnover
11.79 11.41 26.49 86.75 30.66 23.28 66.18 14.71 13.11
Inventory Turnover
0.00 11.80 27.95 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
30.71 28.09 22.86 6.59 2.07 24.37 9.18 1.93 53.52
Days of Inventory on Hand
0.00 30.77 19.80 8.85 0.00 0.00 0.00 0.00 0.00
Average Receivables
3.73 3.62 4.78 8.31 9.97 7.71 3.54 1.65 1.65
Average Payables
0.53 0.61 0.41 0.09 0.22 0.26 0.07 0.30 0.30
Average Inventory
— 0.59 0.39 — — — — — —
Average Assets
25.02 25.15 31.52 37.44 35.54 26.28 15.89 7.02 10.51
Average Common Equity
23.37 22.59 27.03 32.79 32.20 23.59 13.36 8.30 8.31

Fold the line items

Columns are period end dates